Bibliography
- Robarge KD, Brunton SA, Castanedo GM, GDC-0449 – a potent inhibitor of the hedgehog pathway. Bioorg Med Chem Lett 2009;19:5576-81
- Von Hoff DD, LoRusso PM, Rudin CM, Inhibition of the hedgehog pathway is advanced basal-cell carcinoma. N Engl J Med 2009;361:1164-2
- Rudin CM, Hann CL, Laterra J, Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449. N Engl J Med 2009;361:1173-8
- Yauch RL, Dijkgraaf GJ, Alicke B, Smoothened mutations confers resistance to a hedgehog pathway inhibitor in medulloblastoma. Science 2009. [Epub ahead of print]
- Available from: http://clinicaltrials.gov/ct2/show/NCT00957229?term=GDC-0449&rank=1 A study evaluating the efficacy and safety of GDC-0449 (hedgehog pathway inhibitor) in patients with advanced basal cell carcinoma [Last accessed 2 october 2009]
- Available from: http://clinicaltrials.gov/ct2/show/NCT00939484?term=GDC-0449&rank=9 GDC-0449 in treating adult patients with recurrent or refractory medulloblastoma [Last accessed 2 October 2009]
- Available from: http://clinicaltrials.gov/ct2/show/NCT00822458?term=GDC-0449&rank=8 GDC-0449 in treating young patients with medulloblastoma that is recurrent or did not respond to previous treatment [Last accessed 2 October 2009]
- Mahindroo N, Punchihewa C, Fujii N. Hedgehog-Gli signalling pathway inhibitors as anti-cancer drugs. J Med Chem 2009;52:3829-45
- Available from: http://clinicaltrials.gov/ct2/show/NCT00878163?term=GDC-0449&rank=4 GDC-0449 and erlotinib in treating patients with metastatic pancreatic cancer or solid tumours that cannot be removed be surgery [Last accessed 19 October 2009]
- Available from: http://clinicaltrials.gov/ct2/results?term=GDC-0449 GCD-0449 [Last accessed 19 October 2009]
- Available from: http://clinicaltrials.gov/ct2/show/NCT00880308?term=hedgehog&rank=20 Dose finding and safety of oral LDE225 in patients with advanced solid tumors [Last accessed 19 October 2009]
- Available from: http://clinicaltrials.gov/ct2/show/NCT00761696?term=hedgehog&rank=19 A phase 1 study of IPI-926 in patients with advances and/or metastatic solid tumor malignancies [Last accessed 19 October 2009]
- Available from: http://clinicaltrials.gov/ct2/show/NCT00953758?term=hedgehog+inhibitor&rank=1 A study of PF-04449913 in select hematologic malignancies or with dasatinib in chronic myeloid leukemia [Last accessed 19 October 2009]